Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and …
Over the last 12 months, insiders at Boston Scientific Corporation have bought $0 and sold $96.98M worth of Boston Scientific Corporation stock.
On average, over the past 5 years, insiders at Boston Scientific Corporation have bought $2.1M and sold $75.38M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 50,000 shares for transaction amount of $2.1M was made by WICHMANN DAVID S (director) on 2021‑11‑15.
2024-12-02 | Sale | EVP, Human Resources | 6,983 0.0005% | $90.78 | $633,917 | -0.01% | ||
2024-11-27 | Sale | SVP, Global Controller and CAO | 1,336 <0.0001% | $90.65 | $121,105 | -0.35% | ||
2024-11-25 | Sale | EVP& Grp Pres, MedSurg & APAC | 14,010 0.001% | $89.27 | $1.25M | +1.32% | ||
2024-11-21 | Sale | director | 4,877 0.0003% | $91.63 | $446,902 | -1.18% | ||
2024-11-08 | Sale | EVP, Global Operations | 30,580 0.0021% | $87.66 | $2.68M | +2.21% | ||
2024-11-05 | Sale | Chairman, President & CEO | 162,778 0.0111% | $84.75 | $13.79M | +0.25% | ||
2024-11-01 | Sale | EVP, Human Resources | 6,983 0.0005% | $84.33 | $588,876 | +7.76% | ||
2024-10-07 | Sale | Chairman, President & CEO | 162,777 0.0113% | $84.63 | $13.78M | +5.11% | ||
2024-10-07 | Sale | EVP & Group Pres, Cardiology | 132,527 0.0092% | $85.00 | $11.26M | +5.11% | ||
2024-10-01 | Sale | EVP, Human Resources | 6,983 0.0005% | $83.86 | $585,594 | +5.16% | ||
2024-09-05 | Sale | Chairman, President & CEO | 162,777 0.011% | $81.17 | $13.21M | +6.91% | ||
2024-09-03 | Sale | EVP, Human Resources | 6,983 0.0005% | $81.70 | $570,511 | +7.07% | ||
2024-08-28 | Sale | EVP & Group Pres, Cardiology | 14,132 0.001% | $80.00 | $1.13M | +9.07% | ||
2024-08-26 | Sale | EVP& Grp Pres, MedSurg & APAC | 14,012 0.0009% | $79.25 | $1.11M | +8.93% | ||
2024-08-01 | Sale | EVP, Human Resources | 6,983 0.0005% | $74.12 | $517,580 | +12.48% | ||
2024-07-01 | Sale | EVP, Human Resources | 6,983 0.0005% | $77.30 | $539,786 | 0.00% | ||
2024-06-03 | Sale | EVP, Human Resources | 6,983 0.0005% | $75.33 | $526,029 | +10.65% | ||
2024-05-29 | Sale | EVP&Pres, Periph Intervent | 63,802 0.0043% | $75.10 | $4.79M | +11.16% | ||
2024-05-28 | Sale | EVP& Grp Pres, MedSurg & APAC | 14,011 0.001% | $75.34 | $1.06M | +10.84% | ||
2024-05-23 | Sale | EVP and CFO | 47,621 0.0033% | $75.11 | $3.58M | +11.84% |
Mahoney Michael F | Chairman, President & CEO | 1521205 0.1032% | $91.07 | 2 | 25 | +37.05% |
LUDWIG EDWARD J | director | 39398 0.0027% | $91.07 | 1 | 3 | +26.95% |
Dockendorff Charles J | director | 0 0% | $91.07 | 1 | 2 | +35.4% |
ABELE JOHN E | Director Emeritus | 500000 0.0339% | $91.07 | 5 | 212 | +7.41% |
BEST LAWRENCE C | EVP | 232189 0.0158% | $91.07 | 1 | 24 | <0.0001% |
Fidelity Investments | $9.72B | 9.65 | 141.93M | +2.66% | +$251.98M | 0.65 | |
The Vanguard Group | $8.73B | 8.67 | 127.44M | +1.58% | +$136.16M | 0.16 | |
BlackRock | $8.69B | 8.63 | 126.84M | +0.22% | +$18.9M | 0.19 | |
State Street | $4.3B | 4.27 | 62.73M | +0.63% | +$26.96M | 0.18 | |
Massachusetts Financial Services Co Ma | $3.19B | 3.17 | 46.61M | -18.48% | -$723.87M | 0.95 |